Farmaindustria ratifies commitment to innovation access before King of Spain

The King of Spain, Felipe VI, last week received members of the pharma trade group Farmaindustria in an official audience at the Palace, when the monarch got to directly learn about the activity of a sector gathered by 180 companies, in which national and international big, medium and small size enterprises share a common space.

Farmaindustria’s president, Antoni Esteve, gave a short speech, in which he thanked the King for the chance to meet while underlining the commitment of the pharmaceutical industry, which expands both on the economic, industrial and social spheres, since they are inseparable for a sector whose activity is based on researching, developing and making new medicines available for healthcare professionals, with which to take care of citizens’ health.

Mr Esteve stressed the contribution of the pharmaceutical industry to Spain with regards to innovation, qualified employment, high added value production and exports. But he immediately linked these contributions to the social value: “It is clear that our ability to innovate depends on the financial situation of our companies – but we are very conscious that from said situation also depends in part the healthcare of all us as citizens.”